MDMAR

3',4'-Methylenedioxy-4-methylaminorex
Clinical data
Other names	3',4'-Methylenedioxy-4-methylaminorex
Identifiers
	IUPAC name 5-(1,3-benzodioxol-5-yl)-4-methyl-4,5-dihydro-1,3-oxazol-2-amine;
CAS Number	1445573-16-9;
PubChem CID	163190697;
CompTox Dashboard (EPA)	DTXSID201336901 ;
Chemical and physical data
Formula	C11H12N2O3
Molar mass	220.228 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1C(OC(=N1)N)C2=CC3=C(C=C2)OCO3;
	InChI InChI=1S/C11H12N2O3/c1-6-10(16-11(12)13-6)7-2-3-8-9(4-7)15-5-14-8/h2-4,6,10H,5H2,1H3,(H2,12,13); Key:JFKNBDXNCLMRPL-UHFFFAOYSA-N;

3',4'-Methylenedioxy-4-methylaminorex (MDMAR) is a recreational designer drug from the substituted aminorex family, with monoamine-releasing effects.^[1]^[2]^[3]

References

^ McLaughlin G, Morris N, Kavanagh PV, Power JD, Twamley B, O'Brien J, et al. (July 2015). "Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3',4'-methylenedioxy-4-methylaminorex (MDMAR)". Drug Testing and Analysis. 7 (7): 555–64. doi:10.1002/dta.1732. PMC 5331736. PMID 25331619.
^ Zawilska JB, Andrzejczak D (December 2015). "Next generation of novel psychoactive substances on the horizon - A complex problem to face". Drug and Alcohol Dependence. 157: 1–17. doi:10.1016/j.drugalcdep.2015.09.030. PMID 26482089.
^ Maier J, Mayer FP, Brandt SD, Sitte HH (October 2018). "DARK Classics in Chemical Neuroscience: Aminorex Analogues". ACS Chemical Neuroscience. 9 (10): 2484–2502. doi:10.1021/acschemneuro.8b00415. PMC 6287711. PMID 30269490.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.